Acorah Software Products - Accounts Production 16.5.460 true true false 18 November 2024 31 July 2025 31 July 2025 16085815 Mr Sebastien Guilbaud Mr Luke Robinson Mr David Rueda iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16085815 2024-11-17 16085815 2025-07-31 16085815 2024-11-18 2025-07-31 16085815 frs-core:CurrentFinancialInstruments 2025-07-31 16085815 frs-core:ShareCapital 2025-07-31 16085815 frs-bus:PrivateLimitedCompanyLtd 2024-11-18 2025-07-31 16085815 frs-bus:FilletedAccounts 2024-11-18 2025-07-31 16085815 frs-bus:SmallEntities 2024-11-18 2025-07-31 16085815 frs-bus:EntityHasNeverTraded 2024-11-18 2025-07-31 16085815 frs-bus:AuditExempt-NoAccountantsReport 2024-11-18 2025-07-31 16085815 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-18 2025-07-31 16085815 frs-bus:Director1 2024-11-18 2025-07-31 16085815 frs-bus:Director2 2024-11-18 2025-07-31 16085815 frs-bus:Director3 2024-11-18 2025-07-31 16085815 frs-countries:EnglandWales 2024-11-18 2025-07-31
Registered number: 16085815
IRIDA BIOTECH LIMITED
Unaudited Financial Statements
For the Period 18 November 2024 to 31 July 2025
RRT CONSULTING LIMITED
Office 7 35-37 Ludgate Hill
London
EC4M 7JN
IRIDA BIOTECH LIMITED
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
IRIDA BIOTECH LIMITED
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 16085815

| 31 July 2025
--- | ---
| Notes | £ | £
CURRENT ASSETS
Debtors | 4 | 10 |
|  | 10 |
NET CURRENT ASSETS (LIABILITIES) |  |  | 10
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 10
NET ASSETS |  |  | 10
CAPITAL AND RESERVES
Called up share capital | 5 |  | 10
SHAREHOLDERS' FUNDS |  |  | 10

For the period ending 31 July 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Sebastien Guilbaud Director
14/10/2025

The notes on page 2 form part of these financial statements.
Page 1
Page 2
IRIDA BIOTECH LIMITED
Notes to the Financial Statements
For the Period 18 November 2024 to 31 July 2025
Notes to the Financial Statements
1. General Information
IRIDA BIOTECH LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 16085815 . The registered office is 82a James Carter Road, Mildenhall, Bury St. Edmunds, Suffolk, IP28 7DE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
4. Debtors

| 31 July 2025
--- | ---
| £
Due within one year
Other debtors | 10

5. Share Capital

| 31 July 2025
--- | ---
| £
Called Up Share Capital not Paid | 10
Amount of Allotted, Called Up Share Capital | 10

Page 2